export@pu-kang.com            lorena@pu-kang.com
You are here: Home » Products » 优化 » for energy metabolism fda approved phase 3 Benzyl 3-hydroxyazetidine-1-carboxylate


Share to:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
sharethis sharing button

for energy metabolism fda approved phase 3 Benzyl 3-hydroxyazetidine-1-carboxylate

Molecular Formula C11H13NO3
Benzyl 3-hydroxyazetidine-1-carboxylate
Molecular Weight:207.23
  • CAS:128117-22-6

Small size N-heterocyclic ring is an important structure in organic synthesis and pharmaceutical chemistry. Palladium-catalyzed unfunctional lystal amine precursor C-H bond molecularized nearest attractive new method to N-heterocyclic synthesis. However, the reactivity of the high-priced PD intermediate is controlled to form the method of forming the desired C-N ring product is selectively still poor. Here, we report a strategy for controlling the reduction elimination (RE) pathway in the high-priced PD catalysis, and applies the strategy by N-benzylpyridamide PD-catalyzed molecular CH amination to achieve high straintened tetraenzene Azolamide. These reactions represent the first actual synthesis method of benzole, and can obtain a series of composite benzidine from a suitable raw material. The use of a newly designed benzethyl dimethyl dialatine agent is critical because Pd (II) palladium and the palladium of the reagent are advantageous for dynamic C-N loop to obtain a strain ring closure product.


Related News

content is empty!

About Us
Chengdu Pukang has a professional R&D team with rich experience, and innovative ideas, which can meet the various needs of customers from custom synthesis to mass production.
Contact Us
​​​​​​​​​​​​​​No.288 of North Rongtai Avenue,WenJiang district 611137,Chengdu Sichuan
Copyright © 2021 chengdu Pukang Biological Technology Co., Ltd.  Support By Leadong  Sitemap / Private Policy
Leave a Message
Contact us